Substituted indazoles for targeting Hsp90
US-9738643-B2 · Aug 22, 2017 · US
US10927115B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10927115-B2 |
| Application number | US-201916550715-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 26, 2019 |
| Priority date | Aug 6, 2012 |
| Publication date | Feb 23, 2021 |
| Grant date | Feb 23, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Substituted indazoles linked to a substituted adenine with a polyethylene glycol moiety selectively bind to Hsp90. The compounds include detection moieties such as fluorophores and are useful in methods and kits for selective detection of Hsp90 in a sample.
Opening claim text (preview).
The invention claimed is: 1. A compound of formula (I): wherein: A is formula (II): wherein: X is CR 9 or N; Y is CR 3 or N; R 1 is H or C 1-8 -alkyl; R 2 is H or C 1-8 -alkyl; R 3 is H, F, or OCH 3 ; R 4 is H, F, or OCH 3 ; R 5 is H, F, or OCH 3 ; R 6 is C 1-8 -alkyl, halo-C 1-8 -alkyl, hydroxy-C 1-8 -alkyl, C 3-8 -cycloalkyl-C 1-8 -alkyl, C 3-8 -cycloalkenyl-C 1-8 -alkyl, heterocyclyl-C 1-8 -alkyl, aryl-C 1-8 -alkyl, heteroaryl-C 1-8 -alkyl, C 2-8 -alkenyl, C 2-8 -alkynyl, C 3-8 -cycloalkyl, C 3-8 -cycloalkenyl, heterocyclyl, aryl, or heteroaryl; R 7 is H or C 1-8 -alkyl; R 8 is H or C 1-8 -alkyl; or R 7 and R 8 , taken together with the carbon atom to which they are attached, form a C 3-8 -cycloalkyl; R 9 is H or C 1-8 -alkyl; and is the point of attachment in formula (I); X 1 is —C(O)—, —NH—, —O—, —S—, or —S(O) 2 —; L is a divalent linker of the following formula: —(CH 2 ) m —(OCH 2 CH 2 ) n —O—(CH 2 ) p —, wherein: m is 2 or 3; n is 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, or 20; and p is 2 or 3; X 2 is —NR—; R is a detection moiety; and B is formula (III): wherein: R is alkylenyl or heteroalkylenyl; each Y 1 is independently CH or N; each Z 1 , taken together with the carbon atoms to which they are attached, form a heterocyclyl; Z 2 is H or halo; Z 3 is —CH 2 —, —NH—, —O—, or —S—; Z 4 is H or halo; and is the point of attachment in formula (I); wherein the detection moiety comprises a fluorophore or a radioactive compound; wherein the fluorophore is a fluorescein, a rhodamine, a coumarin, a cyanine, or a boron-dipyrromethene; and wherein the radioactive compound is a radioisotope. 2. The compound of claim 1 , wherein: X is N; Y is CR 3 ; R 1 is H; R 2 is H; R 3 is H; R 4 is H; R 5 is H; R 6 is C 1-8 -alkyl or halo-C 1-8 -alkyl; R 7 is C 1-8 -alkyl; and R 8 is C 1-8 -alkyl. 3. The compound of claim 1 , wherein A is: 4. The compound of claim 1 , wherein: m is 3; and p is 3. 5. The compound of claim 1 , wherein n is 4. 6. The compound of claim 1 , wherein the detection moiety comprises a fluorophore. 7. The compound of claim 6 , wherein the fluorophore is a fluorescein. 8. The compound of claim 6 , wherein the detection moiety is: 9. The compound of claim 1 , wherein B is: 10. A pharmaceutical composition comprising a compound of claim 1 and a pharmaceutically acceptable carrier. 11. A kit comprising a compound of claim 1 . 12. A method for detecting heat shock protein 90 in a sample, wherein the method comprises the following steps: a) contacting the sample with the compound of claim 1 ; and b) detecting a signal from the detection moiety. 13. A method for detecting cancer in a subject, wherein the method comprises the following steps: a) contacting a biological sample from the subject with the compound of claim 1 ; and b) detecting a signal from the detection moiety. 14. A method for detecting human immunodeficiency virus in a subject, wherein the method comprises the following steps: a) contacting a biological sample from the subject with the compound of claim 1 ; and b) detecting a signal from the detection moiety.
involving intracellular compounds · CPC title
for cancer · CPC title
condensed with carbocyclic rings or ring systems · CPC title
attached in position 6, e.g. adenine · CPC title
linked by a chain containing hetero atoms as chain links · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.